The blockade of FAK in KPC cells, either by siFAK or by an FAK inhibitor, has been shown to reduce tumor fibrosis [7], whereas the ARF6-AMAP1 pathway may promote focal adhesion dynamics depending on cellular conditions, as mentioned earlier. The gene discussed is ARF6; the disease is neoplasm.